Stay updated on DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Sign up to get notified when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.

Latest updates to the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page
- Check3 days agoChange DetectedA banner announces NIH’s transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) and links to updates and FAQs.SummaryDifference1%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer revision advanced from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check16 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study page now displays a 403 Forbidden error page with the site header and footer shown, indicating restricted access to the content.SummaryDifference18%

- Check52 days agoChange DetectedA related topics section was updated to include 'Type 2 diabetes' and a link to 'MedlinePlus Genetics'. This expands consumer health resource connections related to the study.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded NIH funding note (2015) and updated revision to v3.6.6; removed the explicit listing of Type 2 Diabetes as the condition along with related topics and the older revision v3.6.5, reconfiguring the study’s metadata and context.SummaryDifference0.1%

Stay in the know with updates to DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Enter your email address, and we'll notify you when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.